Correlation Between Cadrenal Therapeutics, and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Hookipa Pharma, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Hookipa Pharma.
Diversification Opportunities for Cadrenal Therapeutics, and Hookipa Pharma
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cadrenal and Hookipa is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Hookipa Pharma
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 1.19 times more return on investment than Hookipa Pharma. However, Cadrenal Therapeutics, is 1.19 times more volatile than Hookipa Pharma. It trades about 0.07 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.03 per unit of risk. If you would invest 782.00 in Cadrenal Therapeutics, Common on August 24, 2024 and sell it today you would earn a total of 619.00 from holding Cadrenal Therapeutics, Common or generate 79.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Hookipa Pharma
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Hookipa Pharma |
Cadrenal Therapeutics, and Hookipa Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Hookipa Pharma
The main advantage of trading using opposite Cadrenal Therapeutics, and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.The idea behind Cadrenal Therapeutics, Common and Hookipa Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |